|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 27.11 USD | -1.56% |
|
-3.97% | -41.45% |
| 08-13 | Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement | MT |
| 08-06 | Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026 | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 277M | 464M | 567M | 631M | 781M | |||||
Total Assets | 692M | 1.17B | 1.14B | 1.66B | 1.66B | |||||
Interest Expense | -21.01M | -63.21M | -83.34M | -73.97M | -82.31M | |||||
Income Tax Expense | -74.89M | -3.84M | 27.58M | 29.38M | 29.75M | |||||
CAPEX | -1.94M | -1.62M | -461K | -1.65M | -1.74M | |||||
EBT | -3.37M | -28.85M | 75.73M | 98.57M | 92.62M | |||||
Gross Profit | 151M | 209M | 326M | 377M | 463M | |||||
D&A | 68.92M | 139M | 149M | 169M | 226M | |||||
Operating Income | 17.63M | 33.32M | 167M | 170M | 180M | |||||
Net Income | 71.52M | -25M | 48.16M | 69.19M | 62.87M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 277M | 464M | 567M | 631M | 781M | |||||
Total Assets | 692M | 1.17B | 1.14B | 1.66B | 1.66B | |||||
Interest Expense | -21.01M | -63.21M | -83.34M | -73.97M | -82.31M | |||||
Income Tax Expense | -74.89M | -3.84M | 27.58M | 29.38M | 29.75M | |||||
D&A | 68.92M | 139M | 149M | 169M | 226M | |||||
CAPEX | -1.94M | -1.62M | -461K | -1.65M | -1.74M | |||||
Gross Profit | 151M | 209M | 326M | 377M | 463M | |||||
Net Income | 71.52M | -25M | 48.16M | 69.19M | 62.87M | |||||
EBT | -3.37M | -28.85M | 75.73M | 98.57M | 92.62M | |||||
Operating Income | 17.63M | 33.32M | 167M | 170M | 180M |
- Stock Market
- Stocks
- COLL Stock
- Financials Collegium Pharmaceutical, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
